Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

Table of Contents

March 1, 2013; Volume 54,Issue 3

This Month in JNM

  • You have access
    This Month in JNM
    Journal of Nuclear Medicine March 1, 2013, 54 (3) 11A-12A;

SNMMI Newsline

  • You have access
    Guidelines for Brain Amyloid Imaging Published
    Journal of Nuclear Medicine March 1, 2013, 54 (3) 13N;
  • You have access
    SNM 2013 Annual Meeting in Vancouver
    Journal of Nuclear Medicine March 1, 2013, 54 (3) 14N;
  • You have access
    SNMMI Receives AHRQ Project Funding
    Journal of Nuclear Medicine March 1, 2013, 54 (3) 14N;
  • You have access
    A Focus on Football Injury
    Journal of Nuclear Medicine March 1, 2013, 54 (3) 16N;
  • You have access
    Choosing Wisely in Nuclear Medicine and Molecular Imaging
    Journal of Nuclear Medicine March 1, 2013, 54 (3) 17N-18N;
  • You have access
    Newsbriefs
    Journal of Nuclear Medicine March 1, 2013, 54 (3) 19N-22N;
  • You have access
    In Memoriam
    Journal of Nuclear Medicine March 1, 2013, 54 (3) 22N-23N;
  • You have access
    From the Literature
    Journal of Nuclear Medicine March 1, 2013, 54 (3) 23N-25N;

Editorial

  • You have access
    Learning: The JNM Editorial Process
    Dominique Delbeke
    Journal of Nuclear Medicine March 1, 2013, 54 (3) 27A-28A;

Focus on Molecular Imaging

  • You have access
    Barriers to Clinical Translation with Diagnostic Drugs
    Lee Josephson and Markus Rudin
    Journal of Nuclear Medicine March 1, 2013, 54 (3) 329-332; DOI: https://doi.org/10.2967/jnumed.112.107615

Clinical Investigations

  • You have access
    18F-Fluoromisonidazole PET/CT: A Potential Tool for Predicting Primary Endocrine Therapy Resistance in Breast Cancer
    Jingyi Cheng, Li Lei, Junyan Xu, Yifei Sun, Yongping Zhang, Xincun Wang, Lingling Pan, Zhimin Shao, Yingjian Zhang and Guangyu Liu
    Journal of Nuclear Medicine March 1, 2013, 54 (3) 333-340; DOI: https://doi.org/10.2967/jnumed.112.111963
  • You have access
    Comparison Between 18F-FDG PET Image–Derived Indices for Early Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer
    Mathieu Hatt, David Groheux, Antoine Martineau, Marc Espié, Elif Hindié, Sylvie Giacchetti, Anne de Roquancourt, Dimitris Visvikis and Catherine Cheze-Le Rest
    Journal of Nuclear Medicine March 1, 2013, 54 (3) 341-349; DOI: https://doi.org/10.2967/jnumed.112.108837
  • You have access
    Assessment of Cellular Proliferation in Tumors by PET Using 18F-ISO-1
    Farrokh Dehdashti, Richard Laforest, Feng Gao, Kooresh I. Shoghi, Rebecca L. Aft, Brian Nussenbaum, Friederike H. Kreisel, Nancy L. Bartlett, Amanda Cashen, Nina Wagner-Johnson and Robert H. Mach
    Journal of Nuclear Medicine March 1, 2013, 54 (3) 350-357; DOI: https://doi.org/10.2967/jnumed.112.111948
  • You have access
    The Role of Delayed 18F-FDG PET Imaging in the Follow-up of Patients with Alveolar Echinococcosis
    Cécile Caoduro, Clémence Porot, Dominique A. Vuitton, Solange Bresson-Hadni, Frédéric Grenouillet, Carine Richou, Hatem Boulahdour and Oleg Blagosklonov
    Journal of Nuclear Medicine March 1, 2013, 54 (3) 358-363; DOI: https://doi.org/10.2967/jnumed.112.109942
  • You have access
    Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT Within Patients with Gastroenteropancreatic Neuroendocrine Tumors
    Damian Wild, Jamshed B. Bomanji, Pascal Benkert, Helmut Maecke, Peter J. Ell, Jean Claude Reubi and Martyn E. Caplin
    Journal of Nuclear Medicine March 1, 2013, 54 (3) 364-372; DOI: https://doi.org/10.2967/jnumed.112.111724
  • You have access
    Myocardial Perfusion Imaging with a Solid-State Camera: Simulation of a Very Low Dose Imaging Protocol
    Ryo Nakazato, Daniel S. Berman, Sean W. Hayes, Mathews Fish, Richard Padgett, Yuan Xu, Mark Lemley, Rafael Baavour, Nathaniel Roth and Piotr J. Slomka
    Journal of Nuclear Medicine March 1, 2013, 54 (3) 373-379; DOI: https://doi.org/10.2967/jnumed.112.110601
  • You have access
    First-in-Man Evaluation of 2 High-Affinity PSMA-Avid Small Molecules for Imaging Prostate Cancer
    John A. Barrett, R. Edward Coleman, Stanley J. Goldsmith, Shankar Vallabhajosula, Neil A. Petry, Steve Cho, Thomas Armor, James B. Stubbs, Kevin P. Maresca, Michael G. Stabin, John L. Joyal, William C. Eckelman and John W. Babich
    Journal of Nuclear Medicine March 1, 2013, 54 (3) 380-387; DOI: https://doi.org/10.2967/jnumed.112.111203
  • You have access
    18F-FPEB, a PET Radiopharmaceutical for Quantifying Metabotropic Glutamate 5 Receptors: A First-in-Human Study of Radiochemical Safety, Biokinetics, and Radiation Dosimetry
    Dean F. Wong, Rikki Waterhouse, Hiroto Kuwabara, Jongho Kim, James R. Brašić, Wichana Chamroonrat, Michael Stabins, Daniel P. Holt, Robert F. Dannals, Terence G. Hamill and P. David Mozley
    Journal of Nuclear Medicine March 1, 2013, 54 (3) 388-396; DOI: https://doi.org/10.2967/jnumed.112.107995

Brief Communication

  • You have access
    Phase 0 Microdosing PET Study Using the Human Mini Antibody F16SIP in Head and Neck Cancer Patients
    Derrek A. Heuveling, Remco de Bree, Danielle J. Vugts, Marc C. Huisman, Leonardo Giovannoni, Otto S. Hoekstra, C. René Leemans, Dario Neri and Guus A.M.S. van Dongen
    Journal of Nuclear Medicine March 1, 2013, 54 (3) 397-401; DOI: https://doi.org/10.2967/jnumed.112.111310

Continuing Education

  • You have access
    Hybrid PET/MR Imaging of the Heart: Potential, Initial Experiences, and Future Prospects
    Christoph Rischpler, Stephan G. Nekolla, Isabel Dregely and Markus Schwaiger
    Journal of Nuclear Medicine March 1, 2013, 54 (3) 402-415; DOI: https://doi.org/10.2967/jnumed.112.105353

Basic Science Investigations

  • You have access
    Inactivation of HNSCC Cells by 90Y-Labeled Cetuximab Strictly Depends on the Number of Induced DNA Double-Strand Breaks
    Jarob Saker, Malte Kriegs, Martin Zenker, Jan-Martin Heldt, Iris Eke, Hans-Jürgen Pietzsch, Reidar Grénman, Nils Cordes, Cordula Petersen, Michael Baumann, Jörg Steinbach, Ekkehard Dikomey and Ulla Kasten-Pisula
    Journal of Nuclear Medicine March 1, 2013, 54 (3) 416-423; DOI: https://doi.org/10.2967/jnumed.111.101857
  • You have access
    3′-Deoxy-3′-18F-Fluorothymidine PET Predicts Response to V600EBRAF-Targeted Therapy in Preclinical Models of Colorectal Cancer
    Eliot T. McKinley, R. Adam Smith, Ping Zhao, Allie Fu, Samir A. Saleh, Md. Imam Uddin, M. Kay Washington, Robert J. Coffey and H. Charles Manning
    Journal of Nuclear Medicine March 1, 2013, 54 (3) 424-430; DOI: https://doi.org/10.2967/jnumed.112.108456
  • You have access
    14C-Methionine Uptake as a Potential Marker of Inflammatory Processes After Myocardial Ischemia and Reperfusion
    Junichi Taki, Hiroshi Wakabayashi, Anri Inaki, Kyoko Imanaka-Yoshida, Michiaki Hiroe, Kazuma Ogawa, Miyako Morooka, Kazuo Kubota, Kazuhiro Shiba, Toshimichi Yoshida and Seigo Kinuya
    Journal of Nuclear Medicine March 1, 2013, 54 (3) 431-436; DOI: https://doi.org/10.2967/jnumed.112.112060
  • You have access
    Modeling Cyclosporine A Inhibition of the Distribution of a P-Glycoprotein PET Ligand, 11C-Verapamil, into the Maternal Brain and Fetal Liver of the Pregnant Nonhuman Primate: Impact of Tissue Blood Flow and Site of Inhibition
    Alice Ban Ke, Sara Eyal, Francisco S. Chung, Jeanne M. Link, David A. Mankoff, Mark Muzi and Jashvant D. Unadkat
    Journal of Nuclear Medicine March 1, 2013, 54 (3) 437-446; DOI: https://doi.org/10.2967/jnumed.112.111732
  • You have access
    18F-FDG Labeling of Mesenchymal Stem Cells and Multipotent Adult Progenitor Cells for PET Imaging: Effects on Ultrastructure and Differentiation Capacity
    Esther Wolfs, Tom Struys, Tineke Notelaers, Scott J. Roberts, Abhishek Sohni, Guy Bormans, Koen Van Laere, Frank P. Luyten, Olivier Gheysens, Ivo Lambrichts, Catherine M. Verfaillie and Christophe M. Deroose
    Journal of Nuclear Medicine March 1, 2013, 54 (3) 447-454; DOI: https://doi.org/10.2967/jnumed.112.108316
  • You have access
    Synthesis and Evaluation of 11C-LY2795050 as a κ-Opioid Receptor Antagonist Radiotracer for PET Imaging
    Ming-Qiang Zheng, Nabeel Nabulsi, Su Jin Kim, Giampaolo Tomasi, Shu-fei Lin, Charles Mitch, Steven Quimby, Vanessa Barth, Karen Rash, John Masters, Antonio Navarro, Eric Seest, Evan D. Morris, Richard E. Carson and Yiyun Huang
    Journal of Nuclear Medicine March 1, 2013, 54 (3) 455-463; DOI: https://doi.org/10.2967/jnumed.112.109512
  • You have access
    Respiratory Motion Correction in Oncologic PET Using T1-Weighted MR Imaging on a Simultaneous Whole-Body PET/MR System
    Christian Würslin, Holger Schmidt, Petros Martirosian, Cornelia Brendle, Andreas Boss, Nina F. Schwenzer and Lars Stegger
    Journal of Nuclear Medicine March 1, 2013, 54 (3) 464-471; DOI: https://doi.org/10.2967/jnumed.112.105296

Special Contributions

  • You have access
    The Future of USP Monographs for PET Drugs
    Sally Schwarz, Jeffrey Norenberg, Marc Berridge, Stephen Dragotakes, Joseph Hung, Jeanne Link, N. Scott Mason, Steve Mattmuller, Richard A. Nickel, Alan Packard, Justin Paolino, Neil Petry, James Ponto, Timothy M. Quinton, Katherine L. Seifert, Dennis Swanson, Ronald E. Weiner and Steven Zigler
    Journal of Nuclear Medicine March 1, 2013, 54 (3) 472-475; DOI: https://doi.org/10.2967/jnumed.112.115089
  • You have access
    Appropriate Use Criteria for Amyloid PET: A Report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer’s Association
    Keith A. Johnson, Satoshi Minoshima, Nicolaas I. Bohnen, Kevin J. Donohoe, Norman L. Foster, Peter Herscovitch, Jason H. Karlawish, Christopher C. Rowe, Maria C. Carrillo, Dean M. Hartley, Saima Hedrick, Virginia Pappas and William H. Thies
    Journal of Nuclear Medicine March 1, 2013, 54 (3) 476-490; DOI: https://doi.org/10.2967/jnumed.113.120618

Book Reviews

  • You have access
    Pattern Recognition Neuroradiology
    E. Edmund Kim
    Journal of Nuclear Medicine March 1, 2013, 54 (3) 491; DOI: https://doi.org/10.2967/jnumed.112.116202
  • You have access
    Nuclear Pharmacy Quick Reference
    Dao Le
    Journal of Nuclear Medicine March 1, 2013, 54 (3) 491; DOI: https://doi.org/10.2967/jnumed.112.116194

Letter to the Editor

  • You have access
    Not-So-Random Errors: Randomized Controlled Trials Are Not the Only Evidence of the Value of PET—Rebuttal
    Rodney J. Hicks, Michael S. Hofman and Robert E. Ware
    Journal of Nuclear Medicine March 1, 2013, 54 (3) 492; DOI: https://doi.org/10.2967/jnumed.112.116020
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 54 (3)
Journal of Nuclear Medicine
Vol. 54, Issue 3
March 1, 2013
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author

Issue highlights

  • First-in-Man Evaluation of 2 High-Affinity PSMA-Avid Small Molecules for Imaging Prostate Cancer
  • Hybrid PET/MR Imaging of the Heart: Potential, Initial Experiences, and Future Prospects
  • Synthesis and Evaluation of 11C-LY2795050 as a κ-Opioid Receptor Antagonist Radiotracer for PET Imaging
Sign up for alerts

Jump to

  • This Month in JNM
  • SNMMI Newsline
  • Editorial
  • Focus on Molecular Imaging
  • Clinical Investigations
  • Brief Communication
  • Continuing Education
  • Basic Science Investigations
  • Special Contributions
  • Book Reviews
  • Letter to the Editor
  • Most Cited
  • Most Read
Loading
  • Initial Clinical Experience with 90Y-FAPI-46 Radioligand Therapy for Advanced-Stage Solid Tumors: A Case Series of 9 Patients
  • Total-Body PET Multiparametric Imaging of Cancer Using a Voxelwise Strategy of Compartmental Modeling
  • Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with 177Lu-PSMA-617 for metastatic castration-reSISTant Prostate Cancer (RESIST-PC): efficacy results of the UCLA cohort
  • Why We Did What We Did: PSMA PET/CT Selection Criteria for the VISION Trial
  • 68Ga-FAPI as a Diagnostic Tool in Sarcoma: Data from the 68Ga-FAPI PET Prospective Observational Trial
More...
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire